文献速递认知障碍与痴呆脑血管病

慢性肾脏病与血浆NfL及其他神经退行性生物标志物的关联:哥德堡H70出生队列研究

Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg.
PubMed 文献 · Neurology · 2023-05-24

在哥德堡H70出生队列70岁人群中,慢性肾脏病(CKD)患者血浆神经丝轻链(P-NfL)中位数18.8 pg/mL高于肾功能正常者的14.1 pg/mL(p < 0.001),而脑MRI和脑脊液标志物在两组间相似;P-NfL最高四分位与随访时新发CKD相关(HR 2.39 [1.21: 4.72])。

要点

  • CKD患者P-NfL中位数18.8 pg/mL,高于肾功能正常者的14.1 pg/mL(p < 0.001)。
  • 校正混杂因素后P-NfL与CKD独立相关(OR 3.231,p < 0.001)。
  • P-NfL最高四分位与随访新发CKD相关(HR 2.39 [1.21: 4.72])。

核心结论

  • 在70岁社区人群中,P-NfL与现患CKD和新发CKD均相关,而脑脊液和影像学指标未因CKD状态而不同。
  • 合并CKD和痴呆的参与者P-NfL水平相似。

研究设计与样本

  • 哥德堡H70出生队列研究,纳入有P-NfL、eGFR和脑结构MRI数据的参与者,并邀请部分参与者采集脑脊液。
  • 纳入744名参与者,其中无CKD者668名(年龄71 [70-71]岁,50%男性),CKD者76名(年龄71 [70-71]岁,39%男性);313名参与者分析了脑脊液生物标志物。
  • 558名个体返回复查eGFR(应答率75%,年龄76 [76; 77]岁,48%男性,新发CKD 76例),中位随访5.5(5.3-6.1)年。

主要发现

  • CKD患者P-NfL中位数18.8 pg/mL,高于肾功能正常者的14.1 pg/mL(p < 0.001)。
  • 脑MRI和脑脊液标志物在CKD组与肾功能正常组间相似。
  • 校正高血压和糖尿病等混杂变量后,P-NfL与CKD独立相关(OR 3.231,p < 0.001)。
  • 在存在Aβ42病理的参与者中,eGFR与脑脊液Aβ42/40相关(R = 0.23,p = 0.004)。
  • P-NfL最高四分位与随访时新发CKD相关(HR 2.39 [1.21: 4.72])。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Studies associate chronic kidney disease (CKD) with neurodegeneration. This study investigated the relationship between kidney function, blood, CSF, and structural brain MRI markers of neurodegeneration in a sample including individuals with and without CKD. METHODS: Participants from the Gothenburg H70 Birth Cohort Study, with data on plasma neurofilament light (P-NfL), estimated glomerular filtration rate (eGFR), and structural brain MRI were included. Participants were invited to also have the CSF collected. The primary endpoint of this study was to determine any association between CKD and P-NfL. Secondary endpoints included cross-sectional associations between CKD, eGFR, and CSF-derived and MRI-derived markers of neurodegeneration and Alzheimer disease (AD) pathology (MRI: cortical thickness, hippocampal volume, lateral ventricle volume, and white matter lesion volume; CSF: β-amyloid (Aβ) 42, Aβ42/40, Aβ42/p-tau, t-tau, p-tau, and NfL). Participants with P-NfL and eGFR at baseline were re-examined on eGFR, 5.5 (5.3-6.1) years (median; IQR) after the first visit, and the predictive value of P-NfL levels on incident CKD was estimated longitudinally, using a Cox proportional hazards model. RESULTS: We included 744 participants, 668 without CKD (age 71 [70-71] years, 50% males) and 76 with CKD (age 71 [70-71] years, 39% males). Biomarkers from the CSF were analyzed in 313 participants. A total of 558 individuals returned for a re-examination of eGFR (75% response rate, age 76 [76; 77] years, 48% males, 76 new cases of CKD). Participants with CKD had higher P-NfL levels than those with normal kidney function (median; 18.8 vs 14.1 pg/mL, p < 0.001), while MRI and CSF markers were similar between the groups. P-NfL was independently associated with CKD after adjustment for confounding variables, including hypertension and diabetes (OR; 3.231, p < 0.001), in a logistic regression model. eGFR and CSF Aβ 42/40: R = 0.23, p = 0.004 correlated in participants with Aβ42 pathology. P-NfL levels in the highest quartile were associated with incident CKD at follow-up (HR; 2.39 [1.21: 4.72]). DISCUSSION: In a community-based cohort of 70-year olds, P-NfL was associated with both prevalent and incident CKD, while CSF and/or imaging measures did not differ by CKD status. Participants with CKD and dementia presented similar levels of P-NfL.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Dittrich A, Ashton NJ, Zetterberg H, et al. Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg. Neurology. 2023. PMID: 37225431. doi:10.1212/WNL.0000000000207419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。